Back to Search
Start Over
Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial.
- Source :
- Clinical Lymphoma, Myeloma & Leukemia; Apr2013, Vol. 13 Issue 2, p99-105, 7p
- Publication Year :
- 2013
Details
- Language :
- English
- ISSN :
- 21522650
- Volume :
- 13
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- Clinical Lymphoma, Myeloma & Leukemia
- Publication Type :
- Academic Journal
- Accession number :
- 92000958
- Full Text :
- https://doi.org/10.1016/j.clml.2012.11.002